1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q1 2019
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q1 2019
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q1 2019
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q1 2019
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q1 2019

3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q1 2019
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q1 2019
3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q1 2019
3.4 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q1 2019

4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q1 2019
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q1 2019
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q1 2018 - Q1 2019
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2019
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2018 - Q1 2019
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q1 2018 - Q1 2019
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q1 2018 - Q1 2019
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2018 - Q1 2019

5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q1 2019
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q1 2019
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2018 - Q1 2019
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q1 2018 - Q1 2019
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q1 2018 - Q1 2019
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q1 2018 - Q1 2019
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q1 2018 - Q1 2019
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q1 2018 - Q1 2019

6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q1 2019
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q1 2019
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q1 2019
6.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q1 2019
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q1 2019
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q1 2019
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q1 2019
6.8 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q1 2019
6.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q1 2019
6.10 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q1 2019

7 Deal Summary by Geography
7.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q1 2019
7.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q1 2019
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q1 2019
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q1 2019

8 Pharmaceuticals & Healthcare, Global, Top Advisors
8.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Q1 2018 - Q1 2019
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Q1 2018 - Q1 2019

9 Further Information
9.1 Methodology
9.2 About GlobalData
9.3 Contact Us
9.4 Disclosure information
9.5 Disclaimer

1.1 List of Tables
Table 1: Pharmaceuticals & Healthcare, Global, Deal Summary, Number of Deals and Deal Values (US$m), Q1 2018 - Q1 2019
Table 2: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), Q1 2019
Table 3: Pharmaceuticals & Healthcare, Global, Top Deals, Q1 2019
Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, Q1 2019
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, , Q1 2018 - Q1 2019
Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$m), Q1 2018 - Q1 2019
Table 8: Pharmaceuticals & Healthcare, Global, Top Initial Public Offering Deals, Q1 2019
Table 9: Pharmaceuticals & Healthcare, Global, Top Secondary Offering Deals, Q1 2019
Table 10: Pharmaceuticals & Healthcare, Global, Top PIPE Deals, Q1 2019
Table 11: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$m), Q1 2018 - Q1 2019
Table 12: Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 13: Pharmaceuticals & Healthcare, Global, Top Venture Capital Deals, Q1 2019
Table 14: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals and Deal Values (%), Q1 2019
Table 15: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$m), Q1 2018 - Q1 2019
Table 16: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 17: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q1 2018 - Q1 2019
Table 18: Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 19: Pharmaceuticals & Healthcare, Global, Top Private Equity Deals, Q1 2019
Table 20: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$m), Q1 2018 - Q1 2019
Table 21: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 23: Pharmaceuticals & Healthcare, Partnership Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 24: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2019
Table 25: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q1 2019
Table 26: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payment, Q1 2019
Table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 28: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q1 2018 - Q1 2019
Table 29: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payment and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 30: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deal Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 31: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 32: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Deal Values, Q1 2019
Table 33: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Total Upfront Payment, Q1 2019
Table 34: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Total Milestone Payment, Q1 2019
Table 35: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 36: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payment (US$ m), Q1 2018 - Q1 2019
Table 37: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q1 2018 - Q1 2019
Table 38: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payment and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 39: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 40: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 41: Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 42: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 43: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 44: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 45: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 46: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 47: Pharmaceuticals & Healthcare, Global, Respiratory, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 48: Pharmaceuticals & Healthcare, Global, Ophthalmology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 49: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 50: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 51: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 52: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 53: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Table 54: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019

1.2 List of Figures
Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$m), Q1 2018 - Q1 2019
Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), Q1 2019
Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), Q1 2019
Figure 4: Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$m), Q1 2018 - Q1 2019
Figure 5: Pharmaceuticals & Healthcare, Global, M&As, by Therapy Area, Number of Deals and Deal Values (US$m), by Therapy Area, Q1 2018 - Q1 2019
Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$m), Q1 2018 - Q1 2019
Figure 8: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 9: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals (%), Q1 2019
Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Deal Values (%), Q1 2019
Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, Q1 2018 - Q1 2019
Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 13: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 14: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, Q1 2018 - Q1 2019
Figure 15: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront & Milestone Payment and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q1 2018 - Q1 2019
Figure 20: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q1 2018 - Q1 2019
Figure 21: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payment and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Number Of Deals, Q1 2018 - Q1 2019
Figure 27: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 28: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 29: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 30: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 31: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 32: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 33: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 34: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 35: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 36: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 37: Pharmaceuticals & Healthcare, Global, Respiratory, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 38: Pharmaceuticals & Healthcare, Global, Ophthalmology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 39: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 40: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 41: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 42: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019
Figure 44: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), Q1 2018 - Q1 2019